|
Forecast Period
|
2026-2030
|
|
Market Size (2024)
|
USD 269.67 million
|
|
Market Size (2030)
|
USD 443.69 million
|
|
CAGR (2025-2030)
|
8.51%
|
|
Fastest Growing Segment
|
ICSI IVF
|
|
Largest Market
|
Abu Dhabi
|
Market Overview
UAE In-Vitro Fertilization (IVF) Market
was valued at USD 269.67 million in 2024 and is expected to reach USD 443.69
million in the forecast period with a CAGR of 8.51% through 2030.
In-Vitro Fertilization (IVF) is a
complex medical procedure used to assist individuals or couples in achieving
pregnancy when natural conception is challenging or not possible. The process
involves fertilizing an egg with sperm outside the body, in a laboratory
setting, and then implanting the resulting embryo into the uterus. Multiple IVF
cycles may be needed for some individuals or couples to achieve a successful
pregnancy. The decision to undergo IVF is often influenced by various factors,
including the underlying cause of infertility, age, and individual preferences.
The UAE government has shown support for the development of healthcare
infrastructure, including reproductive health services. Initiatives that
promote fertility treatments, research, and awareness contribute to the growth
of the IVF market.
Advances in reproductive technologies,
such as improved IVF procedures, preimplantation genetic testing (PGT), and
time-lapse imaging, contribute to higher success rates. Fertility clinics that
adopt and offer the latest technologies attract more patients. Growing
awareness about fertility treatments and the success rates of IVF contributes
to an increased acceptance of these procedures. Education campaigns and
outreach programs play a role in informing the public about available options.
Societal changes, including lifestyle
choices, career priorities, and delayed family planning, contribute to an
increased need for fertility treatments. Individuals and couples are seeking
fertility solutions as they delay childbearing to later stages of life.
Improvements in insurance coverage for fertility treatments can make IVF more
accessible to a broader segment of the population. Policies that cover IVF
procedures can significantly influence the market. Ongoing research and
development in reproductive medicine contribute to the introduction of new and
more effective fertility treatments. Innovations in the field attract both
patients and healthcare providers, driving market growth.
.png)
Download Free Sample Report
Key Market Drivers
Technological
Advancements
Time-lapse imaging involves continuous
monitoring of embryos using specialized incubators equipped with cameras. This
technology allows embryologists to observe the development of embryos in
real-time without disturbing the incubation environment. It provides valuable
information about embryo viability, leading to improved embryo selection and
increased success rates. Preimplantation Genetic Testing (PGT) involves the
screening of embryos for genetic abnormalities before implantation.
There are different types of PGT,
including PGT-A (aneuploidy screening), PGT-M (monogenic/single-gene
disorders), and PGT-SR (structural rearrangements). PGT helps identify
chromosomally normal embryos, reducing the risk of genetic disorders and
increasing the chances of a successful pregnancy. Intracytoplasmic Sperm
Injection (ICSI) involves the direct injection of a single sperm into an egg,
enhancing fertilization rates, especially in cases of male infertility. This
technique has become a standard part of many IVF procedures, contributing to
the treatment's success.
Vitrification is a fast-freezing
technique that prevents ice crystal formation, preserving the structural
integrity of eggs and embryos. This technology has significantly improved the
success rates of egg and embryo freezing, allowing individuals to preserve
their fertility for future use.
AI and machine learning applications are
being integrated into IVF laboratories to analyze large datasets related to
embryo development, patient outcomes, and treatment protocols. These
technologies assist in predicting optimal conditions for embryo culture,
refining treatment plans, and personalizing fertility care. Advancements in
biopsy techniques for obtaining genetic material from embryos have improved the
accuracy and safety of PGT. Techniques like trophectoderm biopsy, where cells
are extracted from the outer layer of the embryo, have become more common.
Next-Generation Sequencing (NGS) is used in PGT for analyzing the genetic
material of embryos with high precision. It allows for comprehensive genetic
screening, providing detailed information about the chromosomal makeup of
embryos.
These specialized pumps are used in the
egg retrieval process during IVF. Advanced ovum aspiration pumps contribute to
the efficiency of the procedure, minimizing trauma to eggs and optimizing the
chances of successful fertilization. Improvements in cryopreservation
techniques, including the use of cryoprotectants and controlled cooling rates,
have enhanced the survival rates of frozen eggs, sperm, and embryos. This has
expanded options for fertility preservation and storage. In certain cases of
mitochondrial disorders, a small amount of mitochondrial DNA from a healthy
donor is used to replace defective mitochondria in the mother's egg. This
technique aims to prevent the transmission of mitochondrial diseases to
offspring. This factor will help in the development of the UAE In-Vitro
Fertilization (IVF) Market.
Increasing Awareness
As awareness increases, individuals and
couples become more informed about fertility issues and the various factors
that can contribute to infertility. This understanding prompts them to seek
medical assistance, leading to a higher demand for fertility treatments like
IVF. Many people may not be aware of the range of fertility treatments
available, including IVF. Increased awareness campaigns and educational
initiatives help individuals understand that options like IVF exist, fostering
a willingness to explore these treatments when needed. Infertility has been
stigmatized in some societies.
However, awareness campaigns aim to
reduce the stigma associated with fertility problems, encouraging individuals
to openly discuss their challenges and seek help without fear of judgment.
This, in turn, contributes to a higher demand for fertility treatments.
Increased awareness encourages individuals to seek medical help earlier in the
fertility journey. Early intervention can be crucial in identifying and
addressing fertility issues promptly, potentially improving the chances of
successful fertility treatments like IVF.
Educational programs, both online and
offline, provide information about reproductive health, fertility, and the
available treatments. These initiatives empower individuals with the knowledge
needed to make informed decisions about their reproductive options. In
September 2024, the "Fertility Your Way" campaign, a collaboration
between UAE-based femtech startup Ovasave and Merck Gulf, gained significant
traction in Dubai and Abu Dhabi. Supported by Dubai Investments and Fakeeh
University Hospital, the initiative featured a mobile screening bus that
offered over 500 free AMH tests at key locations, including workplaces, from
September 16 to 25. This campaign is part of a wider movement to raise
awareness about fertility issues and empower women to take control of their
reproductive health.
Increasing awareness like this is
driving the growth of the UAE's In-Vitro Fertilization (IVF) market by
encouraging open discussions and providing women with the tools to make
informed decisions about their fertility. Awareness campaigns through various
media channels, including television, radio, social media, and healthcare
websites, reach a broad audience. These campaigns help disseminate information
about fertility treatments, creating a higher demand for services like IVF.
When public figures share their experiences with fertility treatments,
including IVF, it can significantly impact public perception. Celebrity
endorsements and stories reduce the sense of isolation around fertility
struggles and inspire others to consider similar treatments.
In November 2023, the UAE introduced
significant reforms to fertility regulations, including relaxed laws
surrounding IVF and egg freezing for non-Muslim, unmarried couples, and the
lifting of the surrogacy ban. The updated legislation now allows unmarried
non-Muslim couples to undergo IVF treatment, provided the eggs and sperm come
from the couple. These legal changes have also established clear guidelines for
the use of embryos and eggs in assisted reproductive procedures. As
awareness of these new laws spreads, there is a growing acceptance of fertility
treatments, driving the expansion of the UAE's In-Vitro Fertilization (IVF)
market. These changes are encouraging more individuals to explore IVF options,
boosting demand for these services.
Support groups and forums where
individuals share their experiences with fertility treatments can contribute to
increased awareness. These platforms provide a sense of community and
encouragement for those considering or undergoing IVF. The availability of
accurate and easily accessible information online allows individuals to
research and understand fertility treatments.
This access empowers them to have more
meaningful discussions with healthcare professionals and make informed
decisions about their fertility journey. Government-sponsored initiatives and
healthcare campaigns can play a pivotal role in raising awareness about
fertility issues and available treatments. These efforts contribute to a more
informed and proactive approach to reproductive health. This factor will pace
up the demand of the UAE In-Vitro Fertilization (IVF) Market.
Rise in Changing Lifestyle and Delayed
Childbearing
Changes in societal norms, career ambitions, and
lifestyle choices have led many individuals and couples to delay family
planning. As people are opting to start families later in life, the likelihood
of fertility challenges increases, making fertility treatments like IVF more
necessary. According to the International Labour Organization (ILO), female
labor force participation in the Arab world has risen from 16% in 1990 to over
18% in 2019, with notable increases in the GCC countries. In the UAE, the rate
jumped from 28% to 52%, and other countries like KSA and Oman saw similar
progress.
Education and career development often take
precedence, leading to delayed childbearing as individuals and couples
prioritize professional goals. Increased focus on women’s empowerment and
gender equality has resulted in more women pursuing careers and higher
education before starting families. This shift contributes to later
pregnancies, increasing demand for fertility treatments. As awareness of
age-related fertility challenges grows, individuals are more likely to seek IVF
when natural conception proves difficult. In the UAE, fertility has
dropped significantly, from 6.7 children per woman in 1960 to around 1.4 in
2022, prompting individuals to explore IVF as an option.
Evolving social norms also support delayed
childbearing, particularly in women’s 30s and 40s, further driving demand for
fertility treatments. Economic factors, such as financial stability, also
contribute to delayed family planning, increasing reliance on treatments like
IVF when couples decide to conceive. Modern lifestyles, including stress,
sedentary habits, and environmental factors, further impact fertility, leading
individuals to seek medical solutions such as IVF.
Advances in IVF technology have made the
procedure more accessible and effective. As individuals and couples become
aware of the success rates and advancements in fertility treatments, they are
more inclined to consider IVF as a viable option. Greater social acceptance of
assisted reproductive technologies, including IVF, has reduced stigma around
seeking fertility treatments.
This acceptance encourages individuals
and couples to explore these options when facing difficulties conceiving.
Globalization and cultural influences contribute to changing perspectives on
family planning. Individuals may adopt family planning practices influenced by
diverse cultural norms, impacting the timing of when they decide to have
children. This factor will accelerate the demand of the UAE In-Vitro
Fertilization (IVF) Market.
Key Market Challenges
Cost
of Treatment
IVF is a complex medical procedure that
involves multiple steps and specialized technologies. The overall cost of IVF
includes expenses related to medications, laboratory procedures, fertility
clinic services, and professional fees. The high cost of these services can be
a barrier for many individuals or couples seeking fertility treatments. IVF
success rates can vary, and multiple treatment cycles may be necessary to
achieve a successful pregnancy. Each cycle incurs additional costs, including
medications, consultations, and laboratory fees. The cumulative expenses of
multiple cycles can be financially burdensome for patients.
Some IVF clinics may recommend or
require additional services, such as preimplantation genetic testing (PGT) or
other diagnostic tests, which contribute to the overall cost. These additional
services can further strain the financial resources of individuals seeking IVF.
Insurance coverage for IVF treatments varies, and not all fertility treatments
may be covered by insurance policies. Limited coverage or the absence of
insurance support for IVF can result in higher out-of-pocket expenses for
patients. Medications used in IVF protocols, such as hormonal injections, can
be expensive. The cost of these medications is often a significant component of
the overall IVF expenses.
Cultural
Stigma
Traditional cultural views in the UAE
often place a strong emphasis on natural conception within the confines of
marriage. Fertility treatments like IVF, which involve assisted reproductive
technologies, may be viewed as deviating from these traditional norms. There
can be a cultural inclination towards privacy regarding personal and family
matters. Infertility and the decision to undergo fertility treatments like IVF
are often considered highly personal issues, leading some individuals or
couples to avoid discussing them openly due to concerns about societal
judgment.
Societal expectations regarding family
planning and the desire for children can exert significant pressure on
individuals and couples. Those facing fertility challenges may feel societal
expectations to conceive naturally, and the inability to do so can contribute
to feelings of inadequacy or shame. Stigma surrounding reproductive health,
particularly issues related to infertility, can be pervasive. Misconceptions or
lack of awareness about fertility treatments may contribute to the
stigmatization of those seeking assistance through IVF. Some cultures may view
medical interventions, especially those related to reproductive health, with a
degree of skepticism or discomfort.
IVF involves medical procedures and
laboratory interventions, which can be perceived differently based on cultural
perspectives. Concerns about being judged or becoming the subject of gossip
within tight-knit communities may discourage individuals or couples from openly
discussing their fertility struggles or the decision to undergo IVF.
Key Market Trends
Telemedicine
in Reproductive Health
Telemedicine allows fertility
specialists to conduct remote consultations with patients, providing an
opportunity for individuals and couples to discuss their fertility concerns,
treatment plans, and progress without the need for in-person visits. Follow-up
appointments can also be conducted through virtual platforms. Telemedicine
enables healthcare providers to perform initial assessments and counseling
sessions remotely. This is particularly beneficial for individuals seeking
information about fertility treatments, including IVF, as they can have
preliminary discussions with specialists from the comfort of their homes.
Telemedicine platforms facilitate the
management of prescription medications required for IVF treatments. The
Emirates Health Services (EHS) Innovation Strategy for 2023-2026 is focused on
creating a sustainable healthcare system, aligning with the National Strategy
for Wellbeing 2031 and the "We the UAE 2031" vision, supporting the
broader goals of the UAE Centennial 2071. As part of this digital healthcare
transformation, the Dubai Health Authority (DHA) reported over 300,000
telemedicine consultations in 2022, reflecting a 24% increase from the previous
year. This integration of technology has been pivotal in modernizing healthcare
delivery, with 129 hospitals in Dubai now offering telemedicine services.
This digital shift is particularly
beneficial in reproductive health, providing remote consultations, follow-up
care, and access to specialists, enabling patients to manage their reproductive
health more conveniently and efficiently. Fertility specialists can discuss
medication protocols, address any concerns, and electronically prescribe
medications, streamlining the process for patients. In certain cases,
telemedicine allows for remote monitoring of patients undergoing IVF
treatments.
Patients may use connected devices or
apps to provide data such as hormone levels or cycle progress, allowing
healthcare providers to monitor and adjust treatment plans as needed.
Telemedicine extends beyond individual consultations to include educational
webinars, online resources, and virtual support groups. This approach helps in
disseminating information about IVF, fertility preservation, and reproductive
health to a wider audience.
Segmental Insights
Technique
Insights
Based on Technique, the ICSI IVF (Intracytoplasmic
Sperm Injection) emerged as the fastest growing segment in the UAE In-Vitro
Fertilization (IVF) market during the forecast period. ICSI is a
specialized form of IVF that involves the direct injection of a single sperm
into an egg. This technique is particularly effective in cases of male
infertility or when there are issues with the sperm's ability to fertilize the
egg. As a result, ICSI often leads to higher fertilization rates, making it a
preferred choice for many couples. The prevalence of male infertility issues,
such as low sperm count or poor sperm motility, has led to an increased demand
for ICSI.
This technique allows fertility specialists to
overcome specific male-related fertility challenges, contributing to its
popularity in the market. ICSI has shown to have high success rates in certain
cases, especially when male infertility factors are involved. Couples may be
more inclined to choose ICSI over conventional IVF due to its proven efficacy
in achieving successful pregnancies. The availability and success of ICSI have
expanded the treatment options for couples facing infertility. As a result, more
individuals and couples are opting for ICSI IVF when traditional IVF methods
may not be as effective in addressing their specific fertility issues.
Fertility clinics specializing in ICSI procedures
often have experienced reproductive endocrinologists and embryologists with
expertise in this technique. The specialized knowledge and skills of the
healthcare professionals contribute to the success and popularity of ICSI in
the IVF market.
Instrument
Insights
Based on Instrument, Ovum Aspiration Pumps emerged as
the dominating segment in the UAE In-Vitro Fertilization (IVF) market in
2024. Ovum aspiration pumps play a crucial role in the egg retrieval
process during IVF. If there have been significant technological advancements
in these pumps, such as improved efficiency, precision, and safety features,
fertility clinics may prefer using them. Clinics adopting state-of-the-art
equipment could attract more patients, contributing to the segment's dominance.
The use of Ovum Aspiration Pumps is associated with
higher success rates in egg retrieval procedures, fertility clinics might
prioritize these pumps to enhance the overall success of IVF treatments.
Patient outcomes and success rates are key factors influencing the choice of
equipment in reproductive medicine. Ovum aspiration pumps are essential for
minimally invasive egg retrieval procedures. If there's a trend towards
minimizing invasiveness in IVF treatments, clinics may opt for advanced Ovum
Aspiration Pumps that allow for a more patient-friendly experience.
The safety and precision of egg retrieval procedures
are paramount in IVF treatments. If Ovum Aspiration Pumps offer superior safety
features and precision in capturing ova, fertility specialists may prefer them,
contributing to the segment's prominence.
Download Free Sample Report
Regional Insights
Based on Region, Abu Dhabi emerged as
the dominating region in the UAE In-Vitro Fertilization (IVF) market in 2024.
Abu Dhabi has a robust healthcare infrastructure with state-of-the-art
facilities and a high standard of medical care. The presence of well-equipped
fertility clinics and specialized medical professionals attracts individuals
seeking IVF treatments. The government of Abu Dhabi has shown a commitment to
promoting healthcare and medical tourism. Initiatives and policies supporting
fertility treatments may contribute to the region's prominence in the IVF
market. Abu Dhabi often invests in research and innovation in the healthcare
sector.
This commitment to advancing medical
technologies and practices can attract leading fertility experts and
researchers to the region, further enhancing its standing in the IVF market.
Abu Dhabi has positioned itself as a medical tourism hub, attracting patients
from the UAE and abroad. The availability of top-notch IVF services and the
reputation of fertility clinics contribute to the region's dominance in the
market. Collaboration with international experts and institutions in the field
of reproductive medicine can elevate the status of Abu Dhabi as a hub for
advanced IVF treatments. This collaboration may result in the adoption of
cutting-edge technologies and practices.
Recent Development
- In 2024, Abu Dhabi recorded a 51% IVF
success rate, up from 42% in 2023, marking a global milestone in fertility
care. The Emirate reported 695 successful births and now hosts 14 IVF centres,
supported by 700 specialists and 2,800 healthcare workers. At the FertiClinic
Fertility and IVF Conference, experts highlighted the integration of AI in
fertility treatments. A key innovation was the introduction of 'AIgorithm' by
ARGC UK, an AI-driven tool for optimizing hormone therapy and embryo selection.
These advancements reinforce Abu Dhabi’s position as a hub for world-class
reproductive medicine and cutting-edge assisted reproductive technologies.
- In October 2024, HealthPlus Fertility
and Cleveland Clinic Abu Dhabi, both part of the M42 group, successfully
performed an ovarian tissue cryopreservation (OTC) procedure on a 32-year-old
Emirati patient diagnosed with Hodgkin lymphoma, a cancer affecting the
lymphatic system. The procedure, conducted at Cleveland Clinic Abu Dhabi under
the guidance of HealthPlus Fertility’s expert team, is a groundbreaking
technique that provides women undergoing cancer treatment with the opportunity
to preserve their fertility. OTC involves the careful removal and preservation
of ovarian tissue, which can later be re-implanted to restore fertility after
the completion of cancer treatment.
- In October 2024, Burjeel Holdings
unveiled the Trust Fertility Clinic at its flagship Burjeel Medical City (BMC),
a cutting-edge facility designed to provide personalized and compassionate care
for families experiencing fertility challenges. The clinic offers a wide array
of fertility treatments customized to meet each patient’s unique needs, while
delivering comprehensive, integrated healthcare services for women throughout
all stages of life.
- In September 2024, Burjeel Holdings PLC,
a prominent super-specialty healthcare provider in the MENA region, revealed
plans to introduce IVF services. The group’s extensive portfolio already
encompasses advanced gynecology, fetal medicine, and pediatric subspecialties.
By adding IVF services, Burjeel aims to provide a holistic approach to women’s
healthcare, ensuring continuous care for women throughout all stages of life.
- In August 2024, the Abu Dhabi Social
Support Authority (SSA) unveiled the details of the "Maternity Leave
Support for Women in the Private Sector" initiative. This initiative is
part of the newly launched Emirati Family Growth Support Programme by the
Department of Community Development in Abu Dhabi. The program aims to extend
the paid maternity leave for Emirati mothers employed in the private sector to
90 days. It also provides financial support to supplement their salary during
the 90-day paid leave, contingent upon approval from their private-sector
employer.
Key Market Players
- Fakin
IVF Fertility Center
- First
IVF Fertility Center
- HelpPlus
Fertility Centre
- The
Dubai Center for Gynecology and Fertility
- New
Hope IVF
- Select
IVF
- Bourn
Hall Fertility Clinic
- HealthPlus
Fertility Center
- Burjeel
Hospital
- ART
Fertility Clinics
|
By Technique
|
By Reagent
|
By Instrument
|
By Infertility
|
By Embryo
|
By Application
|
By End User
|
By Region
|
|
ICSI IVF
Non-ICSI/Traditional IVF
|
Embryo Culture Media
Cryopreservation Media
Sperm Processing Media
Ovum Processing Media
|
Imaging Systems
Incubators
Cryo-systems
Sperm Separation Systems
Ovum Aspiration Pumps
Micromanipulator Systems
Others
|
Female
Male
|
Frozen-Thawed Embryo
Fresh Embryo
|
Fertility Clinics
Hospitals
Others
|
Locals
Expats
Medical Tourists
|
Eastern
Western
Northern & Central
Southern
|
Report Scope
In this report, the UAE In-Vitro Fertilization
(IVF) Market has been segmented into the following categories, in addition to
the industry trends which have also been detailed below:
- UAE In-Vitro Fertilization
(IVF) Market, By
Technique:
o ICSI IVF
o Non-ICSI/Traditional IVF
- UAE In-Vitro Fertilization
(IVF) Market, By
Reagent:
o Embryo Culture Media
o Cryopreservation Media
o Sperm Processing Media
o Ovum Processing Media Others
- UAE In-Vitro Fertilization
(IVF) Market, By
Instrument:
o Imaging Systems
o Incubators
o Cryo-systems
o Sperm Separation Systems
o Ovum Aspiration Pumps
o Micromanipulator Systems
o Others
- UAE In-Vitro Fertilization
(IVF) Market, By
Infertility:
o Female
o Male
- UAE In-Vitro Fertilization
(IVF) Market, By
Embryo:
o Frozen-Thawed Embryo
o Fresh Embryo
- UAE In-Vitro Fertilization
(IVF) Market, By
Application:
o Fertility Clinics
o Hospitals
o Others
- UAE In-Vitro Fertilization
(IVF) Market, By
End User:
o Locals
o Expats
o Medical Tourists
- UAE In-Vitro Fertilization
(IVF) Market, By Region:
o Dubai
o Abu Dhabi
o Sharjah
o Rest of UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies
present in the UAE In-Vitro Fertilization (IVF) Market.
Available Customizations:
UAE In-Vitro Fertilization (IVF) Market report with
the given market data, Tech Sci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
UAE In-Vitro
Fertilization (IVF) Market is an upcoming report to be released soon. If you
wish an early delivery of this report or want to confirm the date of release,
please contact us at [email protected]